MBX Biosciences, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | +86.7% | +219.0% | +43.4% | |
| – | +88.8% | +220.2% | +42.7% | |
| – | +26.1% | +61.7% | +52.6% | |
| – | +90.0% | +224.9% | +42.6% | |
| – | +46.5% | +227.9% | +210.9% | |
| – | +78.6% | -92.9% | +43.5% | |
| – | +14.4% | +181.5% | +40.2% | |
| – | +11.7% | +11.8% | +0.6% | |
| – | +42.5% | +283.5% | -44.2% | |
| – | – | – | +43.4% | |
| – | – | – | – | |
| – | +0.0% | +4.8% | +9.3% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.